HCA Healthcare stock closed at USD 427.71 on September 18, 2026, marking a slight decline of 0.31 percent from the previous session's close of USD 429.04. The company operates within the Health Care Services and Health Care Facilities sectors, maintaining a market capitalization of approximately USD 112.8 billion as reported by Yahoo Finance. Financial performance for the second quarter of fiscal year 2026 showed robust revenue generation with total earnings reaching USD 20.23 billion. Diluted earnings per share (EPS) stood at USD 6.85, providing a solid operating base for investors to evaluate against current valuation metrics and future guidance expectations. Analyst fair value estimates suggest the stock is trading below its intrinsic worth, with Simply Wall St citing a fair value of USD 452.29 as of September 21, 2026. This valuation gap indicates that recent price movements are driven more by market pricing dynamics than by a fundamental business rerating or sharp operational shifts. The stock price remains positioned near the middle of its 52-week trading range, spanning from USD 353.99 to USD 556.52. This positioning suggests moderate volatility and stability relative to recent highs and lows, keeping the investment thesis anchored in long-term fundamentals rather than short-term speculation.